Revised forecast
Fiscal year ending March 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The company recorded ¥326 million in extraordinary losses for the fiscal year ended March 2026. These comprised ¥53 million in losses on disposal of fixed assets, ¥228 million in impairment losses, ¥35 million in provision for the price fluctuation reserve, and ¥9 million in other extraordinary losses.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Ordinary revenue: six months 41,000; full year 81,000（Six months 12.6%; full year 9.7%） |
| Ordinary income | Not disclosed → Ordinary profit: six months 4,000; full year 5,000（Six months 90.6%; full year 41.1%） |
| Profit attributable to owners of the parent | Not disclosed → Net income attributable to owners of parent: six months 2,600; full year 3,250（Six months 81.9%; full year 47.4%） |
| Net income per share | Not disclosed → Net income per share: six months 35.47; full year 44.43 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Ordinary revenue: ¥73,846 million; ordinary profit: ¥3,543 million; net income attributable to owners of parent: ¥2,204 million; net income per share: ¥29.77 |
| Details and amount of extraordinary loss | The company recorded ¥326 million in extraordinary losses for the fiscal year ended March 2026. These comprised ¥53 million in losses on disposal of fixed assets, ¥228 million in impairment losses, ¥35 million in provision for the price fluctuation reserve, and ¥9 million in other extraordinary losses. |
| Dividend forecast revision | The annual dividend forecast for the fiscal year ending March 2027 is ¥13.50 per share, an increase of ¥4.50 from ¥9.00 for the fiscal year ended March 2026. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Ordinary revenue increased due to factors including growth in the number of policies in force. However, the loss ratio rose as pets lived longer on average, veterinary care became more sophisticated, and inflation kept medical fees elevated. The business expense ratio also increased due to costs incurred in transferring policies from other insurers. The forecasts for the fiscal year ending March 2027 are based on assumptions including trends in the pet insurance market, sales and market-expansion initiatives, reductions in policy acquisition costs, and the expected impact of measures to improve the loss ratio.